MThera Pharma
PrivateLast Round
Grant
Dec 18, 2023
Total Funding Raised
$12.06M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MThera Pharma is a biopharmaceutical company that develops innovative multi-target therapeutics for chronic and intractable diseases using a proprietary botanical drug platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MThera Pharma Comparables
Compare MThera Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pangea Bio | 83% | |
| Standard Seed Corporation | 82% | |
| Cellarity | 76% |
MThera Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 18, 2023 | ||||
| Series B | Aug 25, 2022 | ||||
| Series A | Apr 8, 2021 | ||||
| Pre Seed | Jul 2, 2020 | ||||
| Grant | Jun 12, 2020 | ||||
Seed | Mar 4, 2020 |
MThera Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genaxis | Series B |
| ROI Investment Partners | Series A |
| Woori Technology Investment Co., Ltd. | Series A |
| Government of South Korea | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 47% MoM.
- Jan 21, 2026
Monthly visitors increased 54% MoM, reaching 5K.
MThera Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MThera Pharma's valuation, stock price, and market status.
Is MThera Pharma a public or private company?
MThera Pharma is a private company.
What is the current stock price of MThera Pharma?
MThera Pharma is a private company, so its shares have no public market price. Caplight tracks MThera Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MThera Pharma worth (valuation)?
Valuation information for MThera Pharma is not publicly available.
Can I buy MThera Pharma stock?
MThera Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MThera Pharma's last funding round?
MThera Pharma's most recent funding round was Grant on December 18, 2023.
Who are the main investors in MThera Pharma?
Key investors in MThera Pharma include Genaxis, ROI Investment Partners, Woori Technology Investment Co., Ltd., Government of South Korea.
Will MThera Pharma IPO soon?
No public IPO plans have been announced for MThera Pharma.
How can I track MThera Pharma secondary market activity?
Caplight tracks bids, offers, and trades in MThera Pharma's shares on secondary markets.